Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
920,413
-
Share change
-
+460,707
-
Total reported value
-
$6,831,550
-
Price per share
-
$7.42
-
Number of holders
-
11
-
Value change
-
+$3,456,567
-
Number of buys
-
5
-
Number of sells
-
5
Institutional Holders of IMPRIMIS PHARMACEUTICALS INC - COM NEW (IMMY) as of Q3 2014
As of 30 Sep 2014 IMPRIMIS PHARMACEUTICALS INC - COM NEW (IMMY) had 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 920,413 shares of stock of the company.
Largest 10 holders included Opaleye Management Inc., BARD ASSOCIATES INC, VANGUARD GROUP INC, BANK OF AMERICA CORP /DE/, Granite Investment Partners, LLC, REGIONS FINANCIAL CORP, MARATHON CAPITAL MANAGEMENT, BlackRock Fund Advisors, GOLDMAN SACHS GROUP INC, and MORGAN STANLEY.
This table shows 11 institutional shareholders of the security as of 30 Sep 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.